ProShares Ultra Nasdaq Biotechnology
 
公司簡況
財務
派息紀錄
盈利預測
股權變動
ETF簡況
 
 
 
基本資料
種類: ETF
費用比率%: 0.95
資產淨值: 85.11
成立日期: 06/04/2010
 
分析
市值分佈:
53.76%
大市值 		6.31%
中市值 		2.60%
小市值
持股比例加總可能不達100%，原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間： 07/03/2026 05:58) 總持有投資項目: 248  
0%
 
100%
     10大 (31.38%)
代號 名稱 佔比% ▼ 持有日期
URGNUroGen Pharma Ltd0.0527/02/2026
XERSXeris Biopharma Holdings0.0527/02/2026
MNKDMannKind Corp0.0527/02/2026
VTYX--0.0527/02/2026
FTREFortrea Holdings0.0527/02/2026
QUREuniQure NV0.0527/02/2026
AVBPArriVent BioPharma0.0527/02/2026
PCRXPacira BioSciences0.0527/02/2026
AMPHAmphastar Pharmaceuticals0.0527/02/2026
TBPHTheravance Biopharma0.0527/02/2026
GHRSGH Research PLC0.0527/02/2026
BCAXBicara Therapeutics Inc.0.0527/02/2026
SPRYARS Pharmaceuticals0.0527/02/2026
CGEMCullinan Therapeutics0.0527/02/2026
XNCRXencor0.0527/02/2026
CTMXCytomX Therapeutics0.0527/02/2026
ABUSArbutus Biopharma Corp0.0527/02/2026
PHATPhathom Pharmaceuticals0.0427/02/2026
CSTLCastle Biosciences0.0427/02/2026
OMEROmeros Corp0.0427/02/2026
  1    2    3    4    5    6    7   8    9    10    11    12    13  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.